Drugs / TJAOA101
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05459493 | Nov 2022 → Nov 2023 | ovarian dysfunction | Tongji Hospital | Unknown | No outcome recorded |
| Phase 0 | NCT05522634 | Nov 2022 → Nov 2023 | primary ovarian failure | Tongji Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TJAOA101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05522634 ↗ |
| Known as | Tongji Anti-ovarian aging 101 | “TJAOA101 (Tongji Anti-ovarian aging 101), a new TCM recipe” NCT05459493 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “TJAOA101 (Tongji Anti-ovarian aging 101), a new TCM recipe” NCT05459493 ↗ |
| Route | Oral | “The usage of this herbal compound is to take orally twice a day(two sacks per).” NCT05459493 ↗ |